Baldwin Wealth Partners LLC MA Sells 90 Shares of Teleflex Incorporated $TFX

Baldwin Wealth Partners LLC MA lessened its stake in shares of Teleflex Incorporated (NYSE:TFX) by 1.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,520 shares of the medical technology company’s stock after selling 90 shares during the period. Baldwin Wealth Partners LLC MA’s holdings in Teleflex were worth $653,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in TFX. Thurston Springer Miller Herd & Titak Inc. increased its stake in Teleflex by 242.9% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 153 shares during the period. Banque Cantonale Vaudoise bought a new position in Teleflex during the 1st quarter worth $27,000. Costello Asset Management INC acquired a new stake in shares of Teleflex in the 1st quarter valued at $28,000. Brooklyn Investment Group boosted its holdings in shares of Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 150 shares in the last quarter. Finally, Allworth Financial LP boosted its holdings in shares of Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 212 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Insider Activity

In other Teleflex news, Director Andrew A. Krakauer acquired 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.25 per share, with a total value of $115,250.00. Following the transaction, the director owned 7,192 shares in the company, valued at approximately $828,878. The trade was a 16.15% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jaewon Ryu acquired 1,500 shares of the stock in a transaction dated Tuesday, August 5th. The stock was acquired at an average cost of $115.00 per share, with a total value of $172,500.00. Following the completion of the transaction, the director owned 3,727 shares in the company, valued at approximately $428,605. This represents a 67.36% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders acquired 5,500 shares of company stock worth $633,590. 1.40% of the stock is owned by corporate insiders.

Teleflex Stock Down 2.9%

Shares of TFX opened at $124.71 on Friday. The company has a market capitalization of $5.51 billion, a PE ratio of 29.34, a PEG ratio of 1.79 and a beta of 1.05. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $241.41. The stock’s 50-day moving average price is $124.23 and its two-hundred day moving average price is $124.42. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. The firm had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s payout ratio is presently 32.00%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on TFX shares. Wells Fargo & Company reduced their target price on Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Royal Bank Of Canada raised their target price on Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a report on Friday, August 1st. Wall Street Zen downgraded Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. Finally, Mizuho raised their target price on Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $141.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.